Does TALIMOGENE LAHERPAREPVEC Cause Injection site erythema? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Injection site erythema have been filed in association with TALIMOGENE LAHERPAREPVEC (Imlygic). This represents 1.4% of all adverse event reports for TALIMOGENE LAHERPAREPVEC.
21
Reports of Injection site erythema with TALIMOGENE LAHERPAREPVEC
1.4%
of all TALIMOGENE LAHERPAREPVEC reports
2
Deaths
4
Hospitalizations
How Dangerous Is Injection site erythema From TALIMOGENE LAHERPAREPVEC?
Of the 21 reports, 2 (9.5%) resulted in death, 4 (19.0%) required hospitalization.
Is Injection site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TALIMOGENE LAHERPAREPVEC. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does TALIMOGENE LAHERPAREPVEC Cause?
Off label use (196)
Pyrexia (135)
Product storage error (133)
Metastatic malignant melanoma (109)
Circumstance or information capable of leading to medication error (89)
Death (82)
Influenza like illness (82)
Fatigue (70)
Chills (68)
Malignant melanoma (64)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
ADALIMUMAB (8,563)
TIRZEPATIDE (3,844)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
Which TALIMOGENE LAHERPAREPVEC Alternatives Have Lower Injection site erythema Risk?
TALIMOGENE LAHERPAREPVEC vs TALQUETAMAB
TALIMOGENE LAHERPAREPVEC vs TALQUETAMAB-TGVS
TALIMOGENE LAHERPAREPVEC vs TAMIFLU
TALIMOGENE LAHERPAREPVEC vs TAMOXIFEN
TALIMOGENE LAHERPAREPVEC vs TAMSULOSIN